Literature DB >> 23747297

Clerocidin-mediated DNA footprinting discriminates among different G-quadruplex conformations and detects tetraplex folding in a duplex environment.

Matteo Nadai1, Giovanna Sattin, Giorgio Palù, Manlio Palumbo, Sara N Richter.   

Abstract

BACKGROUND: G-quadruplexes are polymorphic non-canonical nucleic acid conformations involved both in physiological and pathological processes. Given the high degree of folding heterogeneity and comparable conformational stabilities, different G-quadruplex forms can occur simultaneously, hence rendering the use of basic instrumental methods for structure determination, like X-ray diffraction or NMR, hardly useful. Footprinting techniques represent valuable and relatively rapid alternative to characterize DNA folding. The natural diterpenoid clerocidin is an alkylating agent that specifically reacts at single-stranded DNA regions, with different mechanisms depending on the exposed nucleotide.
METHODS: Clerocidin was used to footprint G-quadruplex structures formed by telomeric and oncogene promoter sequences (c-myc, bcl-2, c-kit2), and by the thrombin binding aptamer.
RESULTS: The easy modulability of CL reactivity towards DNA bases permitted to discriminate fully and partially protected sites, highlights stretched portions of the G-quadruplex conformation, and discriminate among topologies adopted by one sequence in different environmental conditions. Importantly, CL displayed the unique property to allow detection of G-quadruplex folding within a duplex context.
CONCLUSIONS: CL is a finely performing new tool to unveil G-quadruplex arrangements in DNA sequences under genomically relevant conditions. GENERAL SIGNIFICANCE: Nucleic acid G-quadruplex structures are an emerging research field because of the recent indication of their involvement in a series of key biological functions, in particular in regulation of proliferation-associated gene expression. The use of clerocidin as footprinting agent to identify G-quadruplex structures under genomically relevant conditions may allow detection of new G-quadruplex-based regulatory regions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alkylating agent; Clerocidin; DNA conformation; Footprinting; G-quadruplex; Protection assay

Mesh:

Substances:

Year:  2013        PMID: 23747297     DOI: 10.1016/j.bbagen.2013.05.039

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter.

Authors:  Rosalba Perrone; Matteo Nadai; Ilaria Frasson; Jerrod A Poe; Elena Butovskaya; Thomas E Smithgall; Manlio Palumbo; Giorgio Palù; Sara N Richter
Journal:  J Med Chem       Date:  2013-08-06       Impact factor: 7.446

2.  Finding and characterizing the complexes of drug like molecules with quadruplex DNA: combined use of an enhanced hydroxyl radical cleavage protocol and NMR.

Authors:  Harikrushan Ranpura; Dobroslawa Bialonska; Philip H Bolton
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

3.  Synthesis, Binding and Antiviral Properties of Potent Core-Extended Naphthalene Diimides Targeting the HIV-1 Long Terminal Repeat Promoter G-Quadruplexes.

Authors:  Rosalba Perrone; Filippo Doria; Elena Butovskaya; Ilaria Frasson; Silvia Botti; Matteo Scalabrin; Sara Lago; Vincenzo Grande; Matteo Nadai; Mauro Freccero; Sara N Richter
Journal:  J Med Chem       Date:  2015-12-08       Impact factor: 7.446

4.  Structural and affinity analyses of g-quadruplex DNA aptamers for camptothecin derivatives.

Authors:  Hiroto Fujita; Yuri Imaizumi; Yuuya Kasahara; Shunsuke Kitadume; Hiroaki Ozaki; Masayasu Kuwahara; Naoki Sugimoto
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-29

5.  Conformation and stability of intramolecular telomeric G-quadruplexes: sequence effects in the loops.

Authors:  Giovanna Sattin; Anna Artese; Matteo Nadai; Giosuè Costa; Lucia Parrotta; Stefano Alcaro; Manlio Palumbo; Sara N Richter
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.